Western Canada Oncology Msl Role - Vancouver, Canada - GSK

GSK

Verified Company

Vancouver, Canada

2 weeks ago

Posted by:

Sophia Lee

beBee Recruiter

Description

Site Name:
Canada - Alberta - Calgary, Canada - British Columbia - Vancouver

Posted Date:
Mar

This Medical Science Liaison (Hematology / Oncology) role supporting Western Canada provides non-promotional medical support, helping ensure the safe and effective use of GSK medicines, by creating effective scientific interactions with Healthcare Professionals and professional associations.

Through deep expertise and strategic external interactions, the MSL plays a critical role in developing insights which support the development and execution of innovative medical affairs strategies and plans.

PRIMARY RESPONSIBILITIES

Work collaboratively with the Medical Affairs Director, Scientific Lead and Medical Science Liaison Team to develop and execute Oncology Medical Plans.
Responsible to support the hematology / oncology portfolio.
Establish professional relationships with academic health care professionals, professional associations, and other key stakeholders to reactively provide a fair and balanced scientific exchange of medical information, modeling the highest standards of medical integrity and governance.
Respond to unsolicited inquiries for medical information from external experts.
Operate as the field based scientific/medical expert.
Develop and maintain extensive knowledge of disease, its treatment, and the competitive landscape.
Partner with crossfunctional teams (i.e. Commercial, Market Access, Regulatory) to execute Oncology business plans.
Respond to external expert requests surrounding investigatorinitiated studies.
Work collaboratively with Clinical Development personnel to identify potential clinical trial sites.
Support clinical development activities in Canada and provide scientific support to GSK internal stakeholders, as required.

BASIC QUALIFICATIONS

Advanced postgraduate scientific degree required (i.e. MD, PhD, PharmD).
Experience in hematology / oncology therapy area is necessary to meet changing business needs.
Familiarity with reimbursement in Canada.
Sound negotiation and leadership skills.
Excellent public speaker, with outstanding presentation skills.
Excellent interpersonal and communication skills.
Team orientation and the ability to work closely with crossfunctional partners.
Demonstrated ability to confidently interact with external experts.
Demonstrated strong organizational skills.
Selfstarter and innovator.
Demonstrated professional and ethical behavior.
Knowledge of regulations governing information provision to customers within the pharmaceutical industry.
Strong strategic and analytical skills at the therapeutic level.
Must possess a good understanding of the Canadian marketplace.
A valid driver's license is required for this fieldbased position.
Ability to work independently and ability to travel throughout Canada up to 70%.

PREFERRED QUALIFICATIONS

Prior experience working in the Medical Affairs function for the Pharmaceutical or Biotechnology industry with prior external expert relationships in Hematology / Oncology within Canada is strongly preferred.

Why GSK?

We're uniting science, technology and talent to make a difference in more people's lives, and revolutionising the way we do R&D.

We're combining the power of genetic and genomic insights into what causes disease, with the speed and scale of artificial intelligence and machine learning (AI/ML) to make better predictions about who a treatment might work for, and why.

We believe this powerful combination of data and technology holds the key to fundamentally transforming medical discovery for the better, improving R&D success rates and shaping how even the most challenging diseases, like neurological conditions and cancer, can be both prevented and treated.

No single scientist, nor any one technology can keep us all ahead of disease.

That's why we build important collaborations with commercial and academic partners to advance our understanding of disease and what it takes to get ahead.

In the past three years, we've doubled the number of partnerships we've signed, because of our belief in their significant impact on our process.

Our pipeline currently comprises of more than 60 vaccines and medicines across four core therapeutic areas including infectious diseases, HIV, oncology and immunology as well at pursuing other science-led opportunities outside our core areas.

Many have the potential to be first or best-in-class opportunities for patients and since 2017, we've delivered 13 major approvals and more than doubled the number of potential new vaccines and medicines in Phase 3 and registration to 23.

In 2021 we delivered four major product approvals: Cabenuva for HIV, Jemperli for endometrial cancer, Xevudy for COVID-19 and Apretude, our new long-acting medicine for HIV prevention.

Find out more:
Our approach to R&D.

GSK is a global biopharma company with a special purpose - to unite science, technology and